RxDoctor Payments Data

Mark Lorenz, MD

Otolaryngology · Anchorage, AKNPI 1174649784

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Cochlear Americas at 43.2% of the total. That places this record below the midpoint for otolaryngology clinicians in AK, where the typical reported total is $1,001.

$1,001in general payments, 2019–2025

Across 27 payments — averaging $37.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$432
  • Intersect ENT, Inc.$142
  • Med-el Corporation$88
  • Stryker$86
  • Medtronic$50
  • Axogen$47
  • plus $156 from 7 others

What the payments were for

  • Food & beverage$1,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,001 in reported general payments places this provider in the 50th percentile of 20 otolaryngology providers in Alaska.

See all otolaryngology providers in Alaska

Medicare billing

Part B allowed, 2024
$107,721
Medicare patients
279
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone Sodium Phosphate14$584
Potassium Chloride11$208
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid18$173
Fluticasone Propionate12$127
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$102
Amoxicillin13$43

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →